The Optimizer IVs which delivers CCM therapy, is indicated for patients with moderate-to-severe Chronic Heart Failure (NYHA III) and whose symptoms are not improved by medicines. CCM therapy is most suitable for patients with EF>20% and normal QRS duration that cannot benefit from other device-based treatments such as CRT with pacemaker functionality.
Consult with your doctor as to whether you are a candidate for CCM therapy.
Search the Site
From our blog
- July 2013 Amsterdam Aug 31 – Sept 04 2013 – Welcome at the ESC Congress!
- June 2013 Impulse Dynamics notes great interest in the new OPTIMIZER™ IVs system at the EUROPACE Congress in Athens
- May 2013 The OPTIMIZER™ IVs device was presented to an international audience during the 2013 Heart Failure Congress in Lisboa
- April 2013 The new OPTIMIZER™ IVs device was presented to the German public during the DGK Spring Conference in Mannheim